(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. (A) Transendothelial dextran permeability measured with fluorescence-labeled 40 kDa dextran. Cells were exposed for 72 hours to solvent (control), to aldosterone (aldo), to aldosterone and spironolactone (aldo+spiro), to dexamethasone (dexa), or to dexamethasone and RU486 (dexa+RU). Mean values ± s.e.m. are shown; the number of measurements on individual monolayers is shown in the bars. Asterisk indicates significant difference in comparison with control (P<0.01);
indicates significant difference in comparison with dexamethasone (P<0.02). (B) Transendothelial electrical resistance measured with the electrical cell impedance sensing (ECIS) technique. Cell treatment was as described in section A. Mean values ± s.e.m. are shown; the number of measurements on individual monolayers is shown in the bars. Asterisk indicates significant difference in comparison with control (P<0.01).